We are live on ! Find out more
GRTS

Gritstone bio, Inc. Common Stock

Delisted

GRTS was delisted on the 21st of October, 2024.

43 hedge funds and large institutions have $194M invested in Gritstone bio, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 43 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+43
Holders Change %
% of All Funds
0.98%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.07%
New
43
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

GRTS Hedge Fund Activity: Q3 2018 in Review

43 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q3 2018, worth a combined $194M.

Buyers outnumbered sellers: 43 funds opened new GRTS positions and 0 closed out — a net gain of 43 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Clarus Ventures, opening a new position worth an estimated $36.6M.

  • 43 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q3 2018, up from 0 in Q2 2018.
  • Funds reported $194M of Gritstone bio, Inc. Common Stock stock for Q3 2018.
  • 43 funds opened new Gritstone bio, Inc. Common Stock positions in Q3 2018 and 0 closed out, a net change of +43 holders.
  • The largest Gritstone bio, Inc. Common Stock buyer in Q3 2018 was Clarus Ventures, an estimated $36.6M added.

Based on aggregated 13F filings for Q3 2018.